178 related articles for article (PubMed ID: 33332205)
1. Arecoline suppresses epithelial cell viability by upregulating tropomyosin-1 through the transforming growth factor-β/Smad pathway.
Li L; Gu L; Yao Z; Wang Y; Tang Z; Wu X
Pharm Biol; 2020 Nov; 58(1):1244-1251. PubMed ID: 33332205
[TBL] [Abstract][Full Text] [Related]
2. Arecoline inhibits epithelial cell viability by upregulating the apoptosis pathway: implication for oral submucous fibrosis.
Li M; Gao F; Zhou ZS; Zhang HM; Zhang R; Wu YF; Bai MH; Li JJ; Lin SR; Peng JY
Oncol Rep; 2014 May; 31(5):2422-8. PubMed ID: 24647969
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine modification contributes to arecoline-mediated oral submucosal fibrosis.
Li X; Gao Y; Chen W; Gu Y; Song J; Zhang J; Ai Y
J Oral Pathol Med; 2022 May; 51(5):474-482. PubMed ID: 35377493
[TBL] [Abstract][Full Text] [Related]
4. Arecoline suppresses HaCaT cell proliferation through cell cycle regulatory molecules.
Zhou ZS; Li M; Gao F; Peng JY; Xiao HB; Dai LX; Lin SR; Zhang R; Jin LY
Oncol Rep; 2013 Jun; 29(6):2438-44. PubMed ID: 23525646
[TBL] [Abstract][Full Text] [Related]
5. Activation of TGF-β pathway by areca nut constituents: a possible cause of oral submucous fibrosis.
Khan I; Kumar N; Pant I; Narra S; Kondaiah P
PLoS One; 2012; 7(12):e51806. PubMed ID: 23284772
[TBL] [Abstract][Full Text] [Related]
6. Arecoline suppresses epithelial cell viability through the Akt/mTOR signaling pathway via upregulation of PHLPP2.
Gu L; Xie C; Peng Q; Zhang J; Li J; Tang Z
Toxicology; 2019 May; 419():32-39. PubMed ID: 30910432
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone Suppresses Arecoline-Induced Epithelial-Mesenchymal Transition in Oral Submucous Fibrosis by Epigenetically Reactivating the p53 Pathway.
Zheng L; Guan ZJ; Pan WT; Du TF; Zhai YJ; Guo J
Oncol Res; 2018 Apr; 26(3):483-494. PubMed ID: 28550687
[TBL] [Abstract][Full Text] [Related]
8. Regulation of extracellular matrix genes by arecoline in primary gingival fibroblasts requires epithelial factors.
Thangjam GS; Agarwal P; Balapure AK; Rao SG; Kondaiah P
J Periodontal Res; 2009 Dec; 44(6):736-43. PubMed ID: 19438976
[TBL] [Abstract][Full Text] [Related]
9. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
10. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin (1-7) inhibits arecoline-induced migration and collagen synthesis in human oral myofibroblasts via inhibiting NLRP3 inflammasome activation.
You Y; Huang Y; Wang D; Li Y; Wang G; Jin S; Zhu X; Wu B; Du X; Li X
J Cell Physiol; 2019 Apr; 234(4):4668-4680. PubMed ID: 30246378
[TBL] [Abstract][Full Text] [Related]
12. Senescent epithelial cells remodel the microenvironment for the progression of oral submucous fibrosis through secreting TGF-β1.
Wang Z; Han Y; Peng Y; Shao S; Nie H; Xia K; Xiong H; Su T
PeerJ; 2023; 11():e15158. PubMed ID: 37096061
[TBL] [Abstract][Full Text] [Related]
13. LncRNA LINC00974 activates TGF-β/Smad signaling to promote oral fibrogenesis.
Fang CY; Yu CC; Liao YW; Hsieh PL; Lu MY; Lin KC; Wu CZ; Tsai LL
J Oral Pathol Med; 2019 Feb; 48(2):151-158. PubMed ID: 30447113
[TBL] [Abstract][Full Text] [Related]
14. Epithelial atrophy in oral submucous fibrosis is mediated by copper (II) and arecoline of areca nut.
Khan I; Pant I; Narra S; Radhesh R; Ranganathan K; Rao SG; Kondaiah P
J Cell Mol Med; 2015 Oct; 19(10):2397-412. PubMed ID: 26248978
[TBL] [Abstract][Full Text] [Related]
15. Arecoline induced cell cycle arrest, apoptosis, and cytotoxicity to human endothelial cells.
Tseng SK; Chang MC; Su CY; Chi LY; Chang JZ; Tseng WY; Yeung SY; Hsu ML; Jeng JH
Clin Oral Investig; 2012 Aug; 16(4):1267-73. PubMed ID: 21847594
[TBL] [Abstract][Full Text] [Related]
16. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
17. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
18. Experimental study on TGF-β1-mediated CD147 expression in oral submucous fibrosis.
Wang W; Xiong H; Hu Z; Zhao R; Hu Y; Chen W; Han Y; Yang L; Hu X; Wang C; Mao T; Xia K; Su T
Oral Dis; 2018 Sep; 24(6):993-1000. PubMed ID: 29457855
[TBL] [Abstract][Full Text] [Related]
19. Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes.
Thangjam GS; Kondaiah P
J Periodontal Res; 2009 Oct; 44(5):673-82. PubMed ID: 19364390
[TBL] [Abstract][Full Text] [Related]
20. Role of the arecoline/YAP1/BMP4 pathway in promoting endothelial-mesenchymal transition in oral submucous fibrosis.
Yao M; Li J; Yuan S; Zhu X; Hu Z; Li Q; Cao R; Wang W; Fang C
J Oral Pathol Med; 2020 Apr; 49(4):305-310. PubMed ID: 31397922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
